Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Expert Opinion on Investigational Drugs
|
June 23, 2015
Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease
Licette C Y Liu, Elise Schutte, Ron T Gansevoort, et al.
The Canadian Journal of Cardiology
|
February 26, 2014
A novel approach to drug development in heart failure: towards personalized medicine
Licette C Y Liu, Adriaan A Voors, Mattia A E Valente, et al.
European Journal of Heart Failure
|
January 28, 2014
Heart failure highlights in 2012-2013
Licette C Y Liu, Kevin Damman, Eric Lipsic, et al.
European Journal of Heart Failure
|
November 23, 2016
Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension
Licette C Y Liu, Yoran M Hummel, Peter van der Meer, et al.
Journal of Cardiac Failure
|
July 25, 2017
Clinical and Hemodynamic Correlates and Prognostic Value of VE/VCO<sub>2</sub> Slope in Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Hypertension
Sebastiaan H C Klaassen, Licette C Y Liu, Yoran M Hummel, et al.
European Journal of Heart Failure
|
February 7, 2015
Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction
Adriaan A Voors, Mauro Gori, Licette C Y Liu, et al.
European Heart Journal
|
July 19, 2015
Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial
Elke S Hoendermis, Licette C Y Liu, Yoran M Hummel, et al.
European Journal of Heart Failure
|
October 7, 2017
Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements
Yoran M Hummel, Licette C Y Liu, Carolyn S P Lam, et al.
European Journal of Heart Failure
|
May 6, 2011
Vitamin D status and outcomes in heart failure patients
Licette C Y Liu, Adriaan A Voors, Dirk J van Veldhuisen, et al.
JACC. Heart Failure
|
December 27, 2016
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume
Carolyn S P Lam, Michiel Rienstra, Wan Ting Tay, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Expert Opinion on Investigational Drugs
|
June 23, 2015
Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease
Licette C Y Liu, Elise Schutte, Ron T Gansevoort, et al.
The Canadian Journal of Cardiology
|
February 26, 2014
A novel approach to drug development in heart failure: towards personalized medicine
Licette C Y Liu, Adriaan A Voors, Mattia A E Valente, et al.
European Journal of Heart Failure
|
January 28, 2014
Heart failure highlights in 2012-2013
Licette C Y Liu, Kevin Damman, Eric Lipsic, et al.
European Journal of Heart Failure
|
November 23, 2016
Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension
Licette C Y Liu, Yoran M Hummel, Peter van der Meer, et al.
Journal of Cardiac Failure
|
July 25, 2017
Clinical and Hemodynamic Correlates and Prognostic Value of VE/VCO<sub>2</sub> Slope in Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Hypertension
Sebastiaan H C Klaassen, Licette C Y Liu, Yoran M Hummel, et al.
European Journal of Heart Failure
|
February 7, 2015
Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction
Adriaan A Voors, Mauro Gori, Licette C Y Liu, et al.
European Heart Journal
|
July 19, 2015
Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial
Elke S Hoendermis, Licette C Y Liu, Yoran M Hummel, et al.
European Journal of Heart Failure
|
October 7, 2017
Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements
Yoran M Hummel, Licette C Y Liu, Carolyn S P Lam, et al.
European Journal of Heart Failure
|
May 6, 2011
Vitamin D status and outcomes in heart failure patients
Licette C Y Liu, Adriaan A Voors, Dirk J van Veldhuisen, et al.
JACC. Heart Failure
|
December 27, 2016
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume
Carolyn S P Lam, Michiel Rienstra, Wan Ting Tay, et al.
Page
of 2